Remove 2030 Remove Compounding Remove Patient Care
article thumbnail

Progress in Dermatology Paves the Way for Vaccine Development

Drug Topics

1 “In line with the goals of its Immunization Agenda 2030, WHO has identified a new list of 17 high-priority global endemic pathogens for vaccine research and development, of which skin pathogens account for at least 8, reinforcing the need for continued focus in this area.” References 1. Goh E, Chavatte JM, Lin RTP, et al. Vaccines (Basel).

Vaccines 449
article thumbnail

Too Much of a Good Thing? Unpacking the Rise of Polypharmacy in Seniors

PharmD Live

Understanding the balance between essential and excessive polypharmacy, recognizing its prevalence, and identifying contributing factors are crucial in mitigating its risks and enhancing patient care. At this rate, nearly half of the older population could be impacted by polypharmacy by 2030. According to the U.S.

article thumbnail

FDA Approves Mavyret for Treatment of Acute HCV Infection

Drug Topics

"Mavyret has treated more than 1 million patients with HCV, but we recognize that a significant need remains for patients with acute infection," Roopal Thakkar, MD, executive vice president of research and development and chief scientific officer at AbbVie, said in a release. References 1.

FDA 315